Director, Life Cycle Management (Hematology)
About The Position
The Director, Global Life Cycle Management (LCM) Lead for Hematology is a member of the Hematology Portfolio team within the Oncology Business Unit and is responsible for driving life cycle management strategy and forward-looking planning for the brand, in alignment with the broader brand strategy and hematology development program. This role will play a critical part in ensuring a holistic and integrated view of the program, with a focus on future commercial opportunities across earlier lines of multiple myeloma (including 1L), as well as expansion into plasma cell dyscrasias such as MGUS, SMM, and amyloidosis. As a strategic, cross-functional leader, this individual evaluates competitive dynamics and emerging treatment paradigms to optimize the long-term value of the asset, serving as a key bridge between the clinical development roadmap and brand strategy evolution. The role also provides strategic input and recommendations to the SPT and commercial leadership.
Requirements
- Bachelor's Degree Required
- 12 years of life sciences related experience with a focus on Marketing, Sales and/or Commercial
- Demonstrated ability to lead strategically, drive performance, build alignment, and collaborate across complex organizations
- Strong knowledge of hematology/oncology, particularly multiple myeloma and evolving treatment paradigms (e.g., TCEs, CAR-T, CELMoDs)
- Proven analytical skills, both quantitative and qualitative, with ability to synthesize diverse inputs (clinical, commercial, customer, competitive) into actionable strategies
- Prior experience supporting inline products and/or new indication launches required
- Experience in global or US marketing, including pre-approval planning for specialty oncology products
- Strong analytical and business insight with experience building strategic cases
Nice To Haves
- PhD, PharmD or MBA preferred
Responsibilities
- Support the development and evolution of the global LCM strategy for brand (e.g., assess commercial opportunity across future indications, indication sequencing and prioritization, and geographic expansion) to maximize long-term brand value
- Lead the integration of future indication strategies into global brand planning, ensuring alignment with clinical development filing plans and contributing to a holistic, consistent commercial narrative for the program across lifecycle stages
- Partner with Global Hematology Marketing leadership and cross-functional teams (Clinical, Regulatory, Market Access) to contribute to asset strategy and ensure alignment with US and International teams
- Maintain an informed, forward-looking view of the multiple myeloma and broader hematology landscape, including TCEs, CAR-Ts, and emerging modalities such as CELMoDs, as well as support assessment of implications for the brands positioning and lifecycle strategy
- Synthesize competitive intelligence and evolving treatment trends into actionable insights and recommendations to inform lifecycle planning and future clinical development considerations
- Support the Brand Team in representing the commercial perspective for the product in cross-functional governance forums and key decision-making discussions
Benefits
- annual bonuses or other incentive plans
- equity awards
- pension or retirement benefits
- 401(k) company match
- health and wellness programs
- fitness centers
- insurance benefits (e.g. medical, dental, vision, life and disability)
- paid time off
- family support benefits
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
What This Job Offers
Job Type
Full-time
Career Level
Director
